7
Feb 2026
Water pressure mechanism enables fast amoeboid cancer cell movement
Cancer is one of the leading causes of death worldwide, marked by the uncontrolled growth of abnormal cells.
Stay Informed!
6
Feb 2026
Senescent neutrophils promote tumor survival across cancer types
Renowned as first responders to threatening infections, neutrophils also happen to feature prominently in the microenvironment of tumors, where they and other immune cells play opposing and frequently mutable roles in promoting-or resisting-cancer progression.
6
Feb 2026
European collaboration transforms immune cell data into cancer biomarkers
World Cancer Day, marked on 4 February, is an international day dedicated to raising awareness of cancer, and to encouraging its prevention, detection and treatment.
6
Feb 2026
Dementia collaborative care delivers greater value than Alzheimer’s medication
Programs that match caregivers with patient navigators yield better outcomes than Alzheimer's drug – but combining the two may be best.
6
Feb 2026
New DNA-based vaccine scaffolds boost targeted immune responses to HIV
One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein scaffolding that mimics a virus.
6
Feb 2026
Needle-thin brain implant enables recording and targeted drug delivery
A new type of brain implant may have implications for both brain research and future treatments of neurological diseases such as epilepsy.
6
Feb 2026
Griffith researchers on the cusp of new vaccine to prevent chikungunya
Griffith University researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue.
6
Feb 2026
Investigational anti-clotting drug reduces risk of second ischemic stroke without bleeding concerns
An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic (clot-caused) stroke without raising bleeding concerns, according to a preliminary late-breaking science presentation at the American Stroke Association's International Stroke Conference 2026.
6
Feb 2026
Triple negative breast cancer cells use new strategy to boost metastatic ability
Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs.
6
Feb 2026
11th Innate Killer Summit returns to San Diego, showcasing clinical data that signals renewed momentum in NK cell therapy
The 11th Innate Killer Summit returns, bringing together global leaders advancing natural killer (NK) cell–based immunotherapies.
